News & Events Archives - Page 3 Of 6

2017 DDL Dual Automated Approach for Sizing and Characterizing Budesonide In Suspension

Authors & ContributorsDavid ExlineEmily Landsperger December 19, 2017 Budesonide is a corticosteroid that is commonly administered by means of a nebulizer to help prevent symptoms of asthma, when regularly inhaled. The suspension contains the ingredients micronized budesonide (API), citric acid, edetate disodium dehydrate, polysorbate 80, sodium chloride, sodium citrate and…

adminNov 17, 2022

Category: News & Events

INTFG Fall Symposium: Method Validation Study for the Preparation and Analysis of Ingredient-Specific Particle Sizing by Raman Chemical Imaging as it Relates to the Generic Nasal Spray Suspensions

Gateway Analytical Relocates to New Facility and Expands Capabilities

DDL and Gateway Analytical Announce Joint Agreement

Gateway Analytical to Present on Formulation Development and Establishing Bioequivalence in Drug Products

Gateway Analytical Promotes Expertise in Foreign Particulate Testing Services at the 2016 PDA Universe of Pre-filled Syringes and Injection Devices Conference

Gateway Analytical Achieves the Prestigious ASCLD/LAB-International Accreditation for Forensic Trace Evidence Testing!

Gateway Analytical to Promote Particulate Identification Services at Analytical Symposium and Expo

Gateway Analytical Features Services for Orally Inhaled Drug Products at the Respiratory Drug Delivery Conference in Phoenix

2017 DDL Dual Automated Approach for Sizing and Characterizing Budesonide In Suspension

Gateway Analytical and Chemic Laboratories Announce Joint Cooperation Agreement